Hao Peng

1.7k total citations · 1 hit paper
59 papers, 1.2k citations indexed

About

Hao Peng is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, Hao Peng has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Otorhinolaryngology, 23 papers in Surgery and 19 papers in Oncology. Recurrent topics in Hao Peng's work include Head and Neck Cancer Studies (33 papers), Head and Neck Surgical Oncology (16 papers) and Viral-associated cancers and disorders (7 papers). Hao Peng is often cited by papers focused on Head and Neck Cancer Studies (33 papers), Head and Neck Surgical Oncology (16 papers) and Viral-associated cancers and disorders (7 papers). Hao Peng collaborates with scholars based in China, Switzerland and Thailand. Hao Peng's co-authors include Jun Ma, Ying Sun, Lei Chen, Yan‐Ping Mao, Yuan Zhang, Wen-Fei Li, Ling‐Long Tang, Ai-Hua Lin, Rui Guo and Wen‐Fei Li and has published in prestigious journals such as PLoS ONE, Cancer and Scientific Reports.

In The Last Decade

Hao Peng

55 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma

2019 241 citations Hao Peng, Di Dong et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Hao Peng

Since Specialization

Citations

This map shows the geographic impact of Hao Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Peng more than expected).

Fields of papers citing papers by Hao Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Peng. The network helps show where Hao Peng may publish in the future.

Co-authorship network of co-authors of Hao Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Peng. A scholar is included among the top collaborators of Hao Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Peng. Hao Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of da Vinci SP and Xi surgical systems in urologic surgery: a systematic review and meta-analysis 2025 ·Journal of Robotic Surgery ·(unknown), Hao Peng, Jianwei Li	0
2	USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγ 2025 ·Cell Death and Differentiation ·Hao Luo, (unknown), (unknown), (unknown), Hao Peng, Haiyan Cai, (unknown), (unknown), (unknown), Youping Zhang, Yan V. Sun, (unknown), (unknown), (unknown), Wenxuan Wu, Hu Lei, Hanzhang Xu, Ming He, Yingli Wu	2
3	Development and validation of a comprehensive predictive model for surgical planning in patients with renal cell carcinoma and inferior vena cava tumor thrombus 2024 ·European Journal of Surgical Oncology ·(unknown), Hao Peng, Chao Zheng, Yanan Wang, (unknown), Chunyu Zhang, (unknown), (unknown), Qiang Zhou, (unknown), Junbiao Zhang, Jing Wang, Le Li, Zhihua Wang	0
4	Advancing EGFR mutation subtypes prediction in NSCLC by combining 3D pretrained ConvNeXt, radiomics, and clinical features 2024 ·Frontiers in Oncology ·Hao Peng, (unknown), (unknown), Fang Zhou, Yikai Xu, Jiancheng Yang, Jun Xu	0
5	Isolation, identification, and pathogenicity of two novel goose astrovirus from goslings with severe gout in China 2024 ·Microbial Pathogenesis ·Pengju Xu, Xuying Wang, Jie Wang, (unknown), (unknown), Lei Liu, Hao Peng, Jiajie Li, (unknown), (unknown), Chang Cui, (unknown), Kang Ouyang, Ying Chen, Zuzhang Wei, Weijian Huang, Yifeng Qin	2
6	Predicting anaplastic lymphoma kinase rearrangement status in patients with non-small cell lung cancer using a machine learning algorithm that combines clinical features and CT images 2022 ·Frontiers in Oncology ·Hao Peng, Bo-Yu Deng, (unknown), Jun Xu, Fang Zhou, Zhexing Liu, Wu Zhou, Yikai Xu	8
7	RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma 2022 ·Frontiers in Pharmacology ·Hao Peng, (unknown), Ji‐Tao Wang, (unknown), (unknown), Meng Yang, Yewei Zhang	2
8	Nomogram-aided individual induction chemotherapy regimen selection in advanced nasopharyngeal carcinoma 2021 ·Oral Oncology ·Hao Peng, Lei Chen, Yan‐Ping Mao, Li Tian, Lizhi Liu	6
9	Combining tumor response and personalized risk assessment: Potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy era 2020 ·Radiotherapy and Oncology ·Wei‐Jie Luo, (unknown), Shaobo Liang, Lei Chen, Guan‐Qun Zhou, Hao Peng, Wen‐Fei Li, Xu Liu, Ying Sun, Aihua Lin, Jun Ma, Yan‐Ping Mao	13
10	Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma breakdown → 2019 ·Clinical Cancer Research ·Hao Peng, Di Dong, (unknown), Lu Li, Ling‐Long Tang, Lei Chen, Wen-Fei Li, Yan‐Ping Mao, Wei Fan, Li-Zhi Liu, Li Tian, Ai-Hua Lin, Ying Sun, Jie Tian, Jun Ma	241
11	Plasma Epstein-Barr Virus DNA Load After Induction Chemotherapy Predicts Outcome in Locoregionally Advanced Nasopharyngeal Carcinoma 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Chenglong Huang, (unknown), Rui Guo, Xu Liu, Yan‐Ping Mao, Hao Peng, Li Tian, Aihua Lin, Li Li, Jian‐Yong Shao, Ying Sun, Jun Ma, Ling‐Long Tang	63
12	Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis 2018 ·BMC Cancer ·Hao Peng, Ling‐Long Tang, Xu Liu, Lei Chen, Wen‐Fei Li, Yan‐Ping Mao, Yuan Zhang, Lizhi Liu, Li Tian, Ying Guo, Ying Sun, Jun Ma	19
13	Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy 2017 ·Chinese Journal of Cancer ·Hao Peng, Lei Chen, Ling‐Long Tang, Wen‐Fei Li, Yan‐Ping Mao, Rui Guo, Yuan Zhang, Lizhi Liu, Li Tian, Xu Zhang, Xiaoping Lin, Ying Guo, Ying Sun, Jun Ma	19
14	Induction Chemotherapy Improved Long-term Outcomes of Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: A Propensity Matched Analysis of 5-year Survival Outcomes in the Era of Intensity-modulated Radiotherapy 2017 ·Journal of Cancer ·Hao Peng, Lei Chen, Jiän Zhang, Wen-Fei Li, Yan‐Ping Mao, Yuan Zhang, Lizhi Liu, Li Tian, Ai-Hua Lin, Ying Sun, Jun Ma	29
15	Prognostic Value of Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma with Low Pre-treatment Epstein-Barr Virus DNA: a Propensity-matched Analysis 2016 ·Journal of Cancer ·Hao Peng, Lei Chen, Wen-Fei Li, Rui Guo, Yuan Zhang, Fan Zhang, Lizhi Liu, Li Tian, Ai-Hua Lin, Ying Sun, Jun Ma	14
16	Prognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy 2015 ·Scientific Reports ·Yuan Zhang, Wen-Fei Li, Lei Chen, Yan‐Ping Mao, Rui Guo, Fan Zhang, Hao Peng, Lizhi Liu, Li Li, Qing Liu, Jun Ma	13
17	Prognostic value of the primary lesion apparent diffusion coefficient (ADC) in nasopharyngeal carcinoma: a retrospective study of 541 cases 2015 ·Scientific Reports ·Yuan Zhang, Xu Liu, Yun Zhang, Wen-Fei Li, Lei Chen, Yan‐Ping Mao, Jing-Xian Shen, Fan Zhang, Hao Peng, Qing Liu, Ying Sun, Jun Ma	52
18	Propensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy 2015 ·BMC Cancer ·Wen-Fei Li, Ying-Qin Li, Lei Chen, Yuan Zhang, Rui Guo, Fan Zhang, Hao Peng, Ying Sun, Jun Ma	21
19	Research Progress on Synthesis and Application of Cyclotriphosphazene-based Flame Retardants 2014 ·Chinese Journal of Applied Chemistry ·(unknown), (unknown), Hao Peng, (unknown)	6
20	Efficiency of different annuloplasty in treating functional tricuspid regurgitation and risk factors for recurrence 2014 ·IJC Heart & Vasculature ·Yi Lin, Zhinong Wang, Jia He, Zhiyun Xu, Jian Xiao, (unknown), Hao Peng	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact